Evidence map›Paper›PMID 34816571›Full record

ArticleColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland2022

Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group.

Maurizio Degiuli, Ugo Elmore, Raffaele De Luca, Paola De Nardi, Mariano Tomatis, Alberto Biondi, Roberto Persiani, Leonardo Solaini, Gianluca Rizzo, Domenico Soriero and 15 more

3 registry-linked trialsOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 108 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 6 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05985239 completednot on this mapstarted 2023, after this paper: background citation

Comparing the Safety and Efficacy of Virtual Ileostomy Versus Diverting Ileostomy in Patients Underwent Total Mesorectal Excision for Rectal Cancer: a Propensity-matched Study

TypeobservationalSponsorfan liRan2023 to 2024Enrolled612ConditionsRectal CancerArmsVI, DI
NCT05985252 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Virtual Ileostomy Versus Conventional Loop Ileostomy in Patients Undergoing Low Anterior Resection for Rectal Cancer: A Randomized Controlled Study

TypeinterventionalSponsorDaping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityRan2023 to 2025Enrolled500ConditionsRectal NeoplasmsArmsVirtual ileostomy, Diverting ileostomy
NCT06633133 narecruitingnot on this mapstarted 2024, after this paper: background citation

Comparing the Safety and Efficacy of Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision for Rectal Cancer: a Multicentre, Prospective, Open-label, Blinded Endpoint, PROBE Study

TypeinterventionalSponsorDaping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityRan2024 to 2030Enrolled620ConditionsRectal CancerArmsVirtual ileostomy
3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 6 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. The ILEOSTIM trial: A multicentre randomised controlled trial evaluating the impact of efferent loop stimulation prior to ileostomy reversal on postoperative ileus.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 12 institutions in 2 countries.

Maurizio DegiuliDivision of Surgical Oncology and Digestive Surgery, Department of Oncology, San Luigi University Hospital, University of Turin, Turin, Italy.
Ugo ElmoreDivision of Gastrointestinal Surgery, San Raffaele Hospital, Milan, Italy.
Raffaele De LucaDepartment of Surgical Oncology, IRCCS Istituto Tumori 'G. Paolo II', Bari, Italy.ORCID 0000-0002-9337-0769
Paola De NardiDivision of Gastrointestinal Surgery, San Raffaele Hospital, Milan, Italy.ORCID 0000-0002-9337-6765
Mariano TomatisDepartment of Oncology, University of Turin, Turin, Italy.
Alberto BiondiFondazione Policlinico Gemelli-IRCCS, AREA di Chirurgia Addominale, Rome, Italy.
Roberto PersianiFondazione Policlinico Gemelli-IRCCS, AREA di Chirurgia Addominale, Rome, Italy.
Leonardo SolainiGeneral and Oncologic Surgery, Morgagni-Pierantoni Hospital, Ausl Romagna, Forlì, Italy.
Gianluca RizzoFondazione Policlinico Universitario A. Gemelli-IRCCS, Chirurgia Generale Presidio Columbus, Rome, Italy.
Domenico SorieroSurgical Oncology Surgery, IRCCS Policlinico San Martino, Genoa, Italy.
Desiree CianfloccaDepartment of Surgery, S. Croce e Carle Hospital, Cuneo, Italy.
Marco MiloneDepartment of Clinical Medicine and Surgery, Department of Gastroenterology, Endocrinology and Endoscopic Surgery, University of Naples 'Federico II', Naples, Italy.
Giulia TurriDivision of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynaecology and Paediatrics, University of Verona, Verona, Italy.ORCID 0000-0001-6150-6812
Daniela RegaColorectal Surgical Oncology, Abdominal Oncology Department, Fondazione Giovanni Pascale IRCCS, Naples, Italy.
Paolo DelrioColorectal Surgical Oncology, Abdominal Oncology Department, Fondazione Giovanni Pascale IRCCS, Naples, Italy.
Corrado PedrazzaniDivision of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynaecology and Paediatrics, University of Verona, Verona, Italy.ORCID 0000-0003-2431-6117
Giovanni D De PalmaDepartment of Clinical Medicine and Surgery, Department of Gastroenterology, Endocrinology and Endoscopic Surgery, University of Naples 'Federico II', Naples, Italy.
Felice BorghiDepartment of Surgery, S. Croce e Carle Hospital, Cuneo, Italy.
Stefano ScabiniSurgical Oncology Surgery, IRCCS Policlinico San Martino, Genoa, Italy.
Claudio CocoFondazione Policlinico Universitario A. Gemelli-IRCCS, Chirurgia Generale Presidio Columbus, Università Cattolica del Sacro Cuore, Rome, Italy.
Davide CavaliereGeneral and Oncologic Surgery, Morgagni-Pierantoni Hospital, Ausl Romagna, Forlì, Italy.
Michele SimoneDepartment of Surgical Oncology, IRCCS Istituto Tumori 'G. Paolo II', Bari, Italy.
Riccardo RosatiDivision of Gastrointestinal Surgery, San Raffaele Hospital, Vita Salute University, Milan, Italy.
Rossella ReddavidDivision of Surgical Oncology and Digestive Surgery, Department of Oncology, San Luigi University Hospital, University of Turin, Turin, Italy.ORCID 0000-0003-0603-9953
collaborators from the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group
Agostino Gemelli University Polyclinic · ITUniversity of Turin · ITVita-Salute San Raffaele University · ITAzienda Sanitaria Ospedaliera S.Croce e Carle Cuneo · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITIstituto Tumori Bari · ITOspedale G.B. Morgagni - L.Pierantoni · ITOspedale Policlinico San Martino · ITUniversity of Naples Federico II · ITUniversity of Verona · ITSociety of Surgical Oncology · USUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimAnastomotic leakage after restorative surgery for rectal cancer shows high morbidity and related mortality. Identification of risk factors could change operative planning, with indications for stoma construction. This retrospective multicentre study aims to assess the anastomotic leak rate, identify the independent risk factors and develop a clinical prediction model to calculate the probability of leakage.

methodsThe study used data from 24 Italian referral centres of the Colorectal Cancer Network of the Italian Society of Surgical Oncology. Patients were classified into two groups, AL (anastomotic leak) or NoAL (no anastomotic leak). The effect of patient-, disease-, treatment- and postoperative outcome-related factors on anastomotic leak after univariable and multivariable analysis was measured.

resultsA total of 5398 patients were included, 552 in group AL and 4846 in group NoAL. The overall incidence of leaks was 10.2%, with a mean time interval of 6.8 days. The 30-day leak-related mortality was 2.6%. Sex, body mass index, tumour location, type of approach, number of cartridges employed, weight loss, clinical T stage and combined multiorgan resection were identified as independent risk factors. The stoma did not reduce the leak rate but significantly decreased leak severity and reoperation rate. A nomogram with a risk score (RALAR score) was developed to predict anastomotic leak risk at the end of resection.

conclusionsWhile a defunctioning stoma did not affect the leak risk, it significantly reduced its severity. Surgeons should recognize independent risk factors for leaks at the end of rectal resection and could calculate a risk score to select high-risk patients eligible for protective stoma construction.

Indexed as

Rectal NeoplasmsSurgical OncologyAnastomosis, SurgicalAnastomotic LeakHumansModels, StatisticalPrognosisRare DiseasesRetrospective StudiesRisk Factorscolorectal fistulacolorectal leakagerectal cancerrectal surgerystoma

Identifiers

PMID34816571
PMCPMC9300066
OpenAlexW3214906937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.